Erleada
Tablet, film coated · Oral · Prescription
Uses
ERLEADA is indicated for the treatment of patients with
- Metastatic castration-sensitive prostate cancer (mCSPC)
- Non-metastatic castration-resistant prostate cancer (nmCRPC)
From the FDA label of Janssen Products Lp, version of Jul 2, 2026. Not medical advice: ask your doctor or pharmacist.
Active ingredient
- Apalutamide
Generic name
- Apalutamide
What it looks like
| Imprint | Look | Manufacturer |
|---|---|---|
| AR 60 | Green, Oval, 17 mm | Janssen Products Lp |
| E240 | Gray, Oval, 21 mm | Janssen Products Lp |
Inactive ingredients and allergens
The labels list none of the common allergens and intolerances (lactose, gluten, gelatin, tartrazine, peanut, soy and others).
- Janssen Products Lp, 240 mg/1: silicon dioxide, croscarmellose sodium, hypromellose acetate succinate 16070722 (3 mpa.s), magnesium stearate, microcrystalline cellulose, glyceryl monocaprylocaprate, ferrosoferric oxide, polyvinyl alcohol graft polyethylene glycol copolymer (3:1; 45000 mw), polyvinyl alcohol, unspecified, talc, titanium dioxide
- Janssen Products Lp, 60 mg/1: croscarmellose sodium, hypromellose acetate succinate 16070722 (3 mpa.s), magnesium stearate, microcrystalline cellulose, ferrosoferric oxide, ferric oxide yellow, polyethylene glycol, unspecified, polyvinyl alcohol, unspecified, talc, titanium dioxide, silicon dioxide
From each product's FDA label; they differ between manufacturers and strengths. The app shows every product and finds those without an allergen.
Official FDA label
- Janssen Products Lp on DailyMed, version of Jul 2, 2026
Read the full label as text, with its contents and search, in the app.
Data: FDA NDC Directory, DailyMed labels, Orange Book, Purple Book and Enforcement Reports, updated Nov 17, 2026.